ACCPpostgrads

SGLT2 Inhibitors: Drs. Nuffer and Trujillo discuss the nonglycemic outcomes, clinical implications, and adverse effects associated with SGLT2 inhibitor therapy in patients with type 2 diabetes.

This episode features clinical queries posed by ACCP members. Our experts, James Coons from the University of Pittsburgh, Zach Stacey from St. Louis College of Pharmacy, and Jessica Tilton from the University of Illinois answer questions on a variety of different topics including various uses of amiodarone, ranolazine, sotalol, and ivabradine.

Antimicrobial dosing in pediatric obesity. Drs. Le and Natale discuss their review article "Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing" published in the March 2017 issue of Pharmacotherapy.

The pediatric obesity epidemic. Drs. Le and Natale discuss their review article "Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing" published in the March 2017 issue of Pharmacotherapy.

Dr. Susan Conway is the lead author of Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know in the February 2017 issue of Pharmacotherapy. In this podcast, she provides additional perspectives applicable to clinicians prescribing and monitoring anticoagulation.

Join Dr. Rachel Chennault, Director, ACCP Practice-Based Research Network (PBRN), as she discusses the advantages and opportunities with several members of the ACCP PBRN.

Sam Johnson, Director of Health Policy and Interprofessional Affairs for ACCP, interviews Lee Vermeulen and Glen Schumock, guest editors of Pharmacotherapy's themed issue on the rising costs of pharmaceuticals. Hear their perspectives on cost containment efforts, drug pricing and our current health care environment. Please note, that the opinions expressed on this podcast are of the individuals being interviewed not of ACCP.

ACCP discusses the ACCP Medicare Initiative, the results of the 2016 election, the potential repeal and replace of the ACA, and the opportunities that exist for ACCP as healthcare gets discussed again at the federal level.

A Preview for 2017

ACCP interviews Kim Kelly, founding member of ACCP, about the early days of clinical pharmacy, the beginning of ACCP, and the challenges and success that both ACCP and clinical pharmacy have experienced over the last 37 years.